Skip to content
Search AI Powered

Latest Stories

Pharmacy bodies support pharmacist's petition to stop violence against local pharmacies

National pharmacy bodies have called on the government and NHS leaders to take appropriate action to keep pharmacy teams safe from violence and abuse.

The Pharmaceutical Services Negotiating Committee (PSNC) -- in collaboration with the Association of Independent Multiple Pharmacies (AIMp), the Company Chemists’ Association (CCA), the National Pharmacy Association (NPA), and the Royal Pharmaceutical Society (RPS) -- is supporting an important petition started by Mike Hewitson, a community pharmacy contractor, who has been threatened with stabbing and robbed in his own pharmacy.


The PSNC and the other national pharmacy bodies strongly believe that no healthcare professional should have to deal with this, that and pharmacists and their teams should be better protected.

It said: “Community pharmacies play an integral role in the delivery of primary care and most patients are highly appreciative of the hard work of local pharmacists and pharmacy teams from dispensing medicines and administering vaccines to providing medical advice and health monitoring services.

“However, a minority of patients are not and far too many pharmacy staff are experiencing violence and abuse just for doing their jobs. As an invaluable member of the NHS family, pharmacies should have access to the same security funds that other important areas of primary care like GPs do.”

PSNC’s recent Pharmacy Pressures Survey of 1,132 staff from and 418 bosses of 5,000 pharmacies found that 75 per cent of pharmacies have seen patients turn aggressive when told they cannot have the medication they have been prescribed.

According to survey, 49 per cent of staff say patient abuse is undermining their mental wellbeing and  90 per cent of pharmacy business owners/head office representatives said that they were concerned about the wellbeing of their pharmacy team(s).

PSNC’s support of the ‘Stop violence against local pharmacies’ petition is part of its work with the other pharmacy organisations to continue to raise awareness of the pressures on the sector, including highlighting the abuse that pharmacists and their teams are increasingly experiencing.

PSNC chief executive Janet Morrison said: “Abuse of community pharmacy staff, or any other healthcare professional, is never acceptable, and all in a position of responsibility must make this clear. The increase in abuse of pharmacy staff during the pandemic was an unfortunate trend, but the evidence suggests that abuse directed at pharmacists and their teams is growing in frequency and severity.

"We would very much encourage everyone to sign this petition. The more signatures this petition has, the more credibility it has and the more seriously the Government will have to take this issue.”

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less